tirzepatide and heart palpitations GLP-1 Palpitations: Safety, Causes & Management Does Tirzepatide Increase Heart Rate?

Catalpol inhibits hepatic stellate cell activation by reducing the formation and changing the contents of hepatocyte-derived extracellular vesicles

10.1016/s0928-4257(99)00119-9 112 SikiricP.MikusD.SeiwerthS.GrabarevicZ.RucmanR.PetekM.et al (1997b)

3,000mg

Prioritizing HighRisk Patients To promote equity, clinicians should prioritize patients with: Poor glycemic control despite current therapy High BMI and multiple comorbidities Limited access to consistent medical care High cardiovascular risk profiles Establishing clear, data-driven criteria helps remove subjective bias from decision-making and supports fair access

They may contain contaminants, have lower purity, and lack sterility testing

Weight reduction alone does not reverse central sensitization, the core mechanism of fibromyalgia, making GLP-1 therapy insufficient as a primary pain management strategy